β3 integrins regulate lymphocyte migration and cytokine responses in heart transplant rejection

American Journal of Transplantation

Volumn 7, Issue 5, 2007, Pages 1080-1090

  Lacy Hulbert, A ^a,b   Ueno, T ^c   Ito, T ^c   Jurewicz, M ^c   Izawa, A ^e   Smith, R N ^d   Chase, C M ^d   Tanaka, K ^c   Fiorina, P ^c   Russell, P S ^d   Auchincloss, H ^d   Sayegh, M H ^c   Hynes, R O ^a   Abdi, R ^c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute rejection; Chronic rejection; Extracellular matrix; Integrin; Migration

Indexed keywords

BETA3 INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 1;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC GRAFT REJECTION; CELL ADHESION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; GENE DELETION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN TARGETING; SURVIVAL TIME; T LYMPHOCYTE; TH2 CELL;

EID: 34247525543     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01757.x     Document Type: Article

References (35)

1. Sayegh MH, Carpenter CB. Transplantation 50 years later - Progress, challenges, and promises. N Engl J Med 2004 351 : 2761 2766.
2. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: Present and future therapeutic targets. Nat Immunol 2005 6 : 1182 1190.
3. Hynes RO. Integrins: Bidirectional, allosteric signaling machines. Cell 2002 110 : 673 687.
4. Pribila JT, Quale AC, Mueller KL, Shimizu Y. Integrins and T cell-mediated immunity. Annu Rev Immunol 2004 22 : 157 180.
5. Salido E, Martin B, Barrios Y et al. The PlA2 polymorphism of the platelet glycoprotein IIIA gene as a risk factor for acute renal allograft rejection. J Am Soc Nephrol 1999 10 : 2599 2605.
6. Yamani MH, Starling RC, Young JB et al. Acute vascular rejection is associated with up-regulation of vitronectin receptor (alphavbeta3), increased expression of tissue factor, and activation of the extracellular matrix metalloproteinase induction system. J Heart Lung Transplant 2002 21 : 983 989.
7. Yamani MH, Tuzcu EM, Starling RC et al. Myocardial ischemic injury after heart transplantation is associated with upregulation of vitronectin receptor (alpha(v)beta3), activation of the matrix metalloproteinase induction system, and subsequent development of coronary vasculopathy. Circulation 2002 105 : 1955 1961.
8. Moulder K, Roberts K, Shevach EM, Coligan JE. The mouse vitronectin receptor is a T cell activation antigen. J Exp Med 1991 173 : 343 347.
9. Roberts K, Yokoyama WM, Kehn PJ, Shevach EM. The vitronectin receptor serves as an accessory molecule for the activation of a subset of gamma/delta T cells. J Exp Med 1991 173 : 231 240.
10. Doucey MA, Legler DF, Faroudi M et al. Convergence of beta 1/beta 3 integrin- and TCR/CD8-mediated signals promotes activation of CTL mediated cytotoxicity. J Biol Chem 2003 10 : 10.
11. Weerasinghe D, McHugh KP, Ross FP, Brown EJ, Gisler RH, Imhof BA. A role for the alphavbeta3 integrin in the transmigration of monocytes. J Cell Biol 1998 142 : 595 607.
12. Kishimoto K, Dong VM, Issazadeh S et al. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest 2000 106 : 63 72.
13. Billingham ME, Cary NR, Hammond ME et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990 9 : 587 593.
14. Auchincloss H, Jr., Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A 1993 90 : 3373 3377.
15. Abdi R, Smith RN, Makhlouf L et al. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes 2002 51 : 2489 2495.
16. Weninger W, Crowley MA, Manjunath N, von Andrian UH. Migratory properties of naive, effector, and memory CD8(+) T cells. J Exp Med 2001 194 : 953 966.
17. Zhai Y, Shen XD, Gao F et al. The CD154-CD40 T cell costimulation pathway is required for host sensitization of CD8(+) T cells by skin grafts via direct antigen presentation. J Immunol 2002 169 : 1270 1276.
18. Hodivala-Dilke KM, McHugh KP, Tsakiris DA et al. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 1999 103 : 229 238.
19. Ley K, Kansas GS. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol 2004 4 : 325 335.
20. von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med 2000 343 : 1020 1034.
21. Imhof BA, Weerasinghe D, Brown EJ et al. Cross talk between alpha(v)beta3 and alpha4beta1 integrins regulates lymphocyte migration on vascular cell adhesion molecule 1. Eur J Immunol 1997 27 : 3242 3252.
22. Blystone SD, Graham IL, Lindberg FP, Brown EJ. Integrin alphavbeta3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha5beta1. J Cell Biol 1994 127 : 1129 1137.
23. Thompson RD, Wakelin MW, Larbi KY et al. Divergent effects of platelet-endothelial cell adhesion molecule-1 and beta 3 integrin blockade on leukocyte transmigration in vivo. J Immunol 2000 165 : 426 434.
24. Coito AJ, Onodera K, Kato H, Busuttil RW, Kupiec-Weglinski JW. Fibronectin-mononuclear cell interactions regulate type 1 helper T cell cytokine network in tolerant transplant recipients. Am J Pathol 2000 157 : 1207 1218.
25. Obhrai JS, Oberbarnscheidt MH, Hand TW, Diggs L, Chalasani G, Lakkis FG. Effector T cell differentiation and memory T cell maintenance outside secondary lymphoid organs. J Immunol 2006 176 : 4051 4058.
26. D'Ambrosio D, Iellem A, Colantonio L, Clissi B, Pardi R, Sinigaglia F. Localization of Th-cell subsets in inflammation: Differential thresholds for extravasation of Th1 and Th2 cells. Immunol Today 2000 21 : 183 186.
27. Li XC, Zand MS, Li Y, Zheng XX, Strom TB. On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. J Immunol 1998 161 : 2241 2247.
28. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allografts after treatment with antibodies to ICAM-1 and LFA-1. Science 1992 255 : 1125 1127.
29. Nicholls MR, Gill RG. LFA-1 (CD11a) as a therapeutic target. Am J Transplant 2006 6 : 27.
30. Kashizuka H, Sho M, Nomi T et al. Role of the ICOS-B7h costimulatory pathway in the pathophysiology of chronic allograft rejection. Transplantation 2005 79 : 1045 1050.
31. Paul LC. Chronic allograft nephropathy: An update. Kidney Int 1999 56 : 783 793.
32. McCarty JH, Lacy-Hulbert A, Charest A et al. Selective ablation of [alpha]v integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death. Development 2005 132 : 165 176.
33. Savill J, Dransfield I, Hogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990 343 : 170 173.
34. Rubartelli A, Poggi A, Zocchi MR. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium. Eur J Immunol 1997 27 : 1893 1900.
35. Schulz O, Pennington DJ, Hodivala-Dilke K, Febbraio M, Reis e Sousa C. CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells. J Immunol 2002 168 : 6057 6065.